Wolverine Trading’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $16.6M | Buy |
39,200
+32,800
| +513% | +$11M | 0.01% | 672 |
|
|
2025
Q2 | $1.82M | Buy |
+6,400
| New | +$1.91M | ﹤0.01% | 1779 |
|
|
2025
Q1 | – | Sell |
-4,900
| Closed | -$1.75M | – | 5901 |
|
|
2024
Q4 | $1.75M | Buy |
+4,900
| New | +$1.8M | ﹤0.01% | 2081 |
|
|
2024
Q2 | – | Sell |
-2,900
| Closed | -$666K | – | 5260 |
|
|
2024
Q1 | $666K | Buy |
+2,900
| New | +$654K | ﹤0.01% | 2580 |
|
|
2023
Q4 | – | Sell |
-1,300
| Closed | -$294K | – | 5268 |
|
|
2023
Q3 | $294K | Sell |
1,300
-900
| -41% | -$207K | ﹤0.01% | 3317 |
|
|
2023
Q2 | $484K | Buy |
+2,200
| New | +$487K | ﹤0.01% | 2634 |
|
|
2022
Q4 | – | Sell |
-2,800
| Closed | -$582K | – | 5095 |
|
|
2022
Q3 | $582K | Buy |
+2,800
| New | +$626K | ﹤0.01% | 2486 |
|
|
2022
Q1 | – | Sell |
-6,700
| Closed | -$1.44M | – | 6505 |
|
|
2021
Q4 | $1.44M | Buy |
6,700
+200
| +3% | +$39.3K | ﹤0.01% | 2213 |
|
|
2021
Q3 | $1.21M | Sell |
6,500
-19,300
| -75% | -$3.8M | ﹤0.01% | 2757 |
|
|
2021
Q2 | $4.57M | Buy |
25,800
+19,100
| +285% | +$3.64M | 0.01% | 1219 |
|
|
2021
Q1 | $1.11M | Buy |
6,700
+2,800
| +72% | +$467K | ﹤0.01% | 2623 |
|
|
2020
Q4 | $580K | Sell |
3,900
-5,900
| -60% | -$774K | ﹤0.01% | 2995 |
|
|
2020
Q3 | $990K | Sell |
9,800
-1,400
| -13% | -$154K | ﹤0.01% | 2099 |
|
|
2020
Q2 | $1.34M | Sell |
11,200
-1,400
| -11% | -$158K | ﹤0.01% | 1735 |
|
|
2020
Q1 | $1.22M | Buy |
+12,600
| New | +$1.2M | ﹤0.01% | 1748 |
|
|
2019
Q4 | – | Sell |
-32,100
| Closed | -$2.6M | – | 5246 |
|
|
2019
Q3 | $2.6M | Sell |
32,100
-700
| -2% | -$56.4K | 0.01% | 1255 |
|
|
2019
Q2 | $2.56M | Buy |
32,800
+7,300
| +29% | +$683K | 0.01% | 1340 |
|
|
2019
Q1 | $2.99M | Buy |
+25,500
| New | +$2.97M | 0.01% | 1205 |
|
|
2018
Q4 | – | Sell |
-15,000
| Closed | -$1.92M | – | 5390 |
|
|
2018
Q3 | $1.92M | Sell |
15,000
-9,600
| -39% | -$1.19M | ﹤0.01% | 1712 |
|
|
2018
Q2 | $2.76M | Hold |
24,600
| – | – | 0.01% | 1310 |
|
|
2018
Q1 | $2.76M | Sell |
24,600
-3,700
| -13% | -$470K | 0.01% | 1310 |
|
|
2017
Q4 | $4.19M | Sell |
28,300
-30,700
| -52% | -$3.9M | 0.02% | 991 |
|
|
2017
Q3 | $6.91M | Buy |
59,000
+48,000
| +436% | +$6.13M | 0.03% | 596 |
|
|
2017
Q2 | $1.45M | Sell |
11,000
-2,100
| -16% | -$262K | 0.01% | 1466 |
|
|
2017
Q1 | $1.79M | Buy |
13,100
+4,000
| +44% | +$606K | 0.01% | 1268 |
|
|
2016
Q4 | $1.3M | Sell |
9,100
-13,400
| -60% | -$1.71M | 0.01% | 1675 |
|
|
2016
Q3 | $2.59M | Buy |
22,500
+5,800
| +35% | +$697K | 0.01% | 1145 |
|
|
2016
Q2 | $1.73M | Buy |
+16,700
| New | +$1.86M | 0.01% | 1196 |
|
Other funds holding UTHR
ACA
DGM
Wolverine Trading's UTHR Position: Q3 2025 in Review
Wolverine Trading sold out of United Therapeutics (UTHR) in Q3 2025, closing a stake of 1,307 shares — an estimated $440K sold.
Wolverine Trading first reported a position in UTHR in Q4 2016 and held it in 14 quarters. The position peaked at $2.65M in Q4 2017. 707 funds tracked by Wall St. Rank hold UTHR as of Q3 2025.
- Wolverine Trading reported no remaining United Therapeutics position as of Q3 2025 after selling out during the quarter.
- Wolverine Trading sold 1,307 United Therapeutics shares in Q3 2025, an estimated $440K.
- Wolverine Trading first reported a position in United Therapeutics in Q4 2016 and held it in 14 quarters.
- Wolverine Trading's United Therapeutics position peaked at $2.65M in Q4 2017.
- 707 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.